Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionOakworth Capital, Inc.
Latest Disclosed Ownership2,335 shares
Latest Disclosed Value $ 356,673
Oakworth Capital, Inc. reports 4.89% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 24, 2026 - Oakworth Capital, Inc. filed a 13F-HR form disclosing ownership of 2,335 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $356,671 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 2,455 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -4.89% during the quarter. The current value of the position is $348,289 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 2,335 -120 -4.89 357 5.33 0.0189
2026-01-30 2025-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 2,455 228 10.24 338 18.60 0.0185
2025-11-04 2025-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 2,227 -92 -3.97 286 1.79 0.0165
2025-07-17 2025-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 2,319 0 0.00 281 8.53 0.0181
2025-04-24 2025-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 2,319 0 0.00 259 14.67 0.0180
2025-01-27 2024-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 2,319 0 0.00 226 -15.41 0.0155
2024-10-21 2024-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 2,319 -871 -27.30 267 -21.53 0.0185
2024-07-19 2024-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 3,190 -612 -16.10 340 -7.63 0.0248
2024-04-22 2024-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 3,802 -6 -0.16 368 -4.43 0.0277
2024-01-31 2023-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 3,808 -5 -0.13 384 -1.03 0.0308
2023-10-31 2023-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 3,813 -71 -1.83 388 -0.77 0.0353
2023-07-28 2023-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 3,884 -50 -1.27 392 8.31 0.0333
2023-05-02 2023-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 3,934 -227 -5.46 362 -4.24 0.0324
2023-02-03 2022-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 4,161 0 0.00 377 19.30 0.0362
2022-10-31 2022-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 4,161 -60 -1.42 316 -11.48 0.0349
2022-08-05 2022-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 4,221 0 0.00 357 -3.51 0.0359
2022-04-11 2022-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 4,221 -300 -6.64 370 -6.33 0.0319
2022-02-07 2021-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 4,521 0 0.00 395 6.76 0.0336
2021-11-10 2021-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 4,521 0 0.00 370 -10.19 0.0357
2021-07-20 2021-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 4,521 0 0.00 412 6.74 0.0411
2021-04-30 2021-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 4,521 -23 -0.51 386 -10.02 0.0438
2021-02-12 2020-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 4,544 -105 -2.26 429 6.19 0.0556
2020-11-09 2020-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 4,649 105 2.31 404 1.76 0.0655
2020-08-11 2020-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 4,544 -209 -4.40 397 1.28 0.0713
2020-05-07 2020-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 4,753 0 0.00 392 -12.69 0.0921
2020-01-31 2019-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 4,753 -195 -3.94 449 4.42 0.0788
2019-11-13 2019-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 4,948 -403 -7.53 430 -12.07 0.0834
2019-08-02 2019-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 5,351 9 0.17 489 -4.86 0.0932
2019-05-06 2019-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 5,342 0 0.00 514 12.23 0.1053
2019-02-13 2018-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 5,342 0 0.00 458 -0.43 0.1043
2018-10-25 2018-09-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 5,342 -603 -10.14 460 2.45 0.0920
2018-08-07 2018-06-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 5,945 0 0.00 449 -1.54 0.0932
2018-05-09 2018-03-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 5,945 0 0.00 456 -10.59 0.1089
2018-01-22 2017-12-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 5,945 0 0.00 510 1.80 0.1200
2017-11-08 2017-09-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 5,945 0 0.00 501 1.01 0.1287
2017-07-31 2017-06-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 5,945 0 0.00 496 12.22 0.1358
2017-04-26 2017-03-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 5,945 -1,283 -17.75 442 -11.07 0.1280
2017-01-27 2016-12-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 7,228 320 4.63 497 -8.81 0.1634
2016-10-24 2016-09-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,908 0 0.00 545 -0.73 0.1888
2016-07-20 2016-06-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,908 132 1.95 549 11.81 0.2054
2016-05-13 2016-03-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,776 0 0.00 491 -15.78 0.1961
2016-01-26 2015-12-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,776 400 6.27 583 -0.51 0.2425
2015-10-29 2015-09-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,376 0 0.00 586 -11.48 0.3085
2015-08-14 2015-06-30 13F/A-1 NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,376 -1,500 -19.05 662 -17.46 0.3133
2015-07-14 2015-06-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,353 575
2015-05-12 2015-03-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 7,876 0 0.00 802 9.86 0.3705
2015-02-24 2014-12-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 7,876 1,523 23.97 730 27.85 0.3777
2014-10-09 2014-09-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,353 0 0.00 571 -0.70 0.3351
2014-07-14 2014-06-30 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,353 0 0.00 575 6.48 0.3496
2014-04-10 2014-03-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 6,353 3,195 101.17 540 112.60 0.3535
2014-01-27 2013-12-31 13F NOVARTIS AG-ADR FOREIGN EQUITIES 66987V109 3,158 3,158 254 0.1795
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.